Agency Releases Information About Part B Prescription Drugs Subject to IRA Inflation Rebates

Agency Releases Information About Part B Prescription Drugs Subject to IRA Inflation Rebates

Today, the Biden administration announced (press release; fact sheet) it will begin enforcing a provision of the Inflation Reduction Act (IRA) on April 1 that penalizes drug companies for raising prices on Medicare prescription drugs faster than inflation. The Centers for Medicare & Medicaid Services (CMS) estimate that Medicare beneficiaries who take the 27 Part B drugs and biologics subject… (Testa, March 15, 2023) #Cost-Sharing, #Drug Pricing